FDA Orange Book · active-ingredient family
Protein hydrolysate
Protein hydrolysate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:AMINOSOL 5% · NDA 005932
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| AMINOSOL 5% | ABBVIE | NDA 005932 | — | Jan 31, 1985 | |
| HYPROTIGEN 5% | B BRAUN | NDA 006170 | — | Jan 10, 1984 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Protein hydrolysate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

